WEKO3
アイテム
{"_buckets": {"deposit": "197008cb-17a5-48f9-a8ed-6eb21e90a60a"}, "_deposit": {"created_by": 2, "id": "2099", "owners": [2], "pid": {"revision_id": 0, "type": "depid", "value": "2099"}, "status": "published"}, "_oai": {"id": "oai:nagasaki-u.repo.nii.ac.jp:00002099", "sets": ["9"]}, "author_link": ["9680", "9688", "9677", "9676", "9683", "9682", "9678", "9686", "9684", "9687", "9681", "9679", "9685"], "item_2_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2016-10-01", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "19", "bibliographicPageEnd": "2880", "bibliographicPageStart": "2877", "bibliographicVolumeNumber": "55", "bibliographic_titles": [{"bibliographic_title": "Internal Medicine"}]}]}, "item_2_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "A 35-year-old non-HIV patient developed pulmonary cryptococcosis after the initiation of infliximab. He recovered by fluconazole treatment and completed the therapy for a total of 6 months. However, he experienced a relapse 16 months later during retreatment with infliximab, revealing an interesting clinical course contradicting retreatment. This case also represents the first case of relapsed pulmonary cryptococcosis suspected during treatment with a biologic agent. Both of these aspects generated important clinical questions about the length of pulmonary cryptococcosis treatment and the necessity of introducing a second prophylaxis for such patients.", "subitem_description_type": "Abstract"}]}, "item_2_description_63": {"attribute_name": "引用", "attribute_value_mlt": [{"subitem_description": "Internal Medicine, 55(19), pp.2877-2880; 2016", "subitem_description_type": "Other"}]}, "item_2_publisher_33": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "日本内科学会"}]}, "item_2_relation_12": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type": "isIdenticalTo", "subitem_relation_type_id": {"subitem_relation_type_id_text": "10.2169/internalmedicine.55.6969", "subitem_relation_type_select": "DOI"}}]}, "item_2_rights_13": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "c 2016 The Japanese Society of Internal Medicine."}]}, "item_2_source_id_7": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "09182918", "subitem_source_identifier_type": "ISSN"}]}, "item_2_source_id_8": {"attribute_name": "EISSN", "attribute_value_mlt": [{"subitem_source_identifier": "13497235", "subitem_source_identifier_type": "ISSN"}]}, "item_2_text_62": {"attribute_name": "出版者別言語", "attribute_value_mlt": [{"subitem_text_value": "Japanese Society of Internal Medicine"}]}, "item_2_version_type_16": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Takazono, Takahiro"}], "nameIdentifiers": [{"nameIdentifier": "9676", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sawai, Toyomitsu"}], "nameIdentifiers": [{"nameIdentifier": "9677", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tashiro, Masato"}], "nameIdentifiers": [{"nameIdentifier": "9678", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Saijo, Tomomi"}], "nameIdentifiers": [{"nameIdentifier": "9679", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamamoto, Kazuko"}], "nameIdentifiers": [{"nameIdentifier": "9680", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Imamura, Yoshifumi"}], "nameIdentifiers": [{"nameIdentifier": "9681", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Miyazaki, Taiga"}], "nameIdentifiers": [{"nameIdentifier": "9682", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Suyama, Naofumi"}], "nameIdentifiers": [{"nameIdentifier": "9683", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Izumikawa, Koichi"}], "nameIdentifiers": [{"nameIdentifier": "9684", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kakeya, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "9685", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yanagihara, Katsunori"}], "nameIdentifiers": [{"nameIdentifier": "9686", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Mukae, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "9687", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kohno, Shigeru"}], "nameIdentifiers": [{"nameIdentifier": "9688", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2020-12-21"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "IntMed55_2877.pdf", "filesize": [{"value": "2.0 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 2000000.0, "url": {"label": "IntMed55_2877.pdf", "url": "https://nagasaki-u.repo.nii.ac.jp/record/2099/files/IntMed55_2877.pdf"}, "version_id": "ffd4c238-e361-46fc-a053-1e27f6a0dcb7"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Biological agents", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Infliximab", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Pulmonary cryptococcosis", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Relapse", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Tumor necrosis factor α inhibitor", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Relapsed Pulmonary Cryptococcosis during Tumor Necrosis Factor α Inhibitor Treatment", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Relapsed Pulmonary Cryptococcosis during Tumor Necrosis Factor α Inhibitor Treatment"}]}, "item_type_id": "2", "owner": "2", "path": ["9"], "permalink_uri": "http://hdl.handle.net/10069/37294", "pubdate": {"attribute_name": "公開日", "attribute_value": "2017-05-16"}, "publish_date": "2017-05-16", "publish_status": "0", "recid": "2099", "relation": {}, "relation_version_is_last": true, "title": ["Relapsed Pulmonary Cryptococcosis during Tumor Necrosis Factor α Inhibitor Treatment"], "weko_shared_id": -1}
Relapsed Pulmonary Cryptococcosis during Tumor Necrosis Factor α Inhibitor Treatment
http://hdl.handle.net/10069/37294
http://hdl.handle.net/10069/372947adbf269-308c-4a5a-b6b0-6a5b1aa1d1a1
名前 / ファイル | ライセンス | アクション |
---|---|---|
IntMed55_2877.pdf (2.0 MB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2017-05-16 | |||||
タイトル | ||||||
タイトル | Relapsed Pulmonary Cryptococcosis during Tumor Necrosis Factor α Inhibitor Treatment | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Biological agents | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Infliximab | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Pulmonary cryptococcosis | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Relapse | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Tumor necrosis factor α inhibitor | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
Takazono, Takahiro
× Takazono, Takahiro× Sawai, Toyomitsu× Tashiro, Masato× Saijo, Tomomi× Yamamoto, Kazuko× Imamura, Yoshifumi× Miyazaki, Taiga× Suyama, Naofumi× Izumikawa, Koichi× Kakeya, Hiroshi× Yanagihara, Katsunori× Mukae, Hiroshi× Kohno, Shigeru |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | A 35-year-old non-HIV patient developed pulmonary cryptococcosis after the initiation of infliximab. He recovered by fluconazole treatment and completed the therapy for a total of 6 months. However, he experienced a relapse 16 months later during retreatment with infliximab, revealing an interesting clinical course contradicting retreatment. This case also represents the first case of relapsed pulmonary cryptococcosis suspected during treatment with a biologic agent. Both of these aspects generated important clinical questions about the length of pulmonary cryptococcosis treatment and the necessity of introducing a second prophylaxis for such patients. | |||||
書誌情報 |
Internal Medicine 巻 55, 号 19, p. 2877-2880, 発行日 2016-10-01 |
|||||
出版者 | ||||||
出版者 | 日本内科学会 | |||||
出版者別言語 | ||||||
Japanese Society of Internal Medicine | ||||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 09182918 | |||||
EISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 13497235 | |||||
DOI | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | DOI | |||||
関連識別子 | 10.2169/internalmedicine.55.6969 | |||||
権利 | ||||||
権利情報 | c 2016 The Japanese Society of Internal Medicine. | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
引用 | ||||||
内容記述タイプ | Other | |||||
内容記述 | Internal Medicine, 55(19), pp.2877-2880; 2016 |